earnings
confidence high
sentiment positive
materiality 0.80
iRadimed Q3 revenue up 42% to $10.9M; raises full-year guidance
IRADIMED CORP
2021-Q3 EPS reported
$0.43
revenue$29,941,721
- Q3 2021 revenue $10.9M (+42% YoY); GAAP diluted EPS $0.20, non-GAAP $0.23.
- Full-year 2021 guidance raised: revenue $41.4-41.6M, GAAP EPS $0.60-0.61, non-GAAP $0.70-0.71.
- Gross profit margin improved to 77.1% from 74.6% in Q3 2020; domestic sales 79.5% of revenue.
- Nine-month operating cash flow $7.9M vs $3.3M; free cash flow $7.5M vs $3.0M.